830
Views
39
CrossRef citations to date
0
Altmetric
Research Article

Intraperitoneal injection of cigarette smoke extract induced emphysema, and injury of cardiac and skeletal muscles in BALB/C mice

, , , , , , & show all
Pages 18-31 | Received 01 Aug 2012, Accepted 05 Nov 2012, Published online: 07 Dec 2012

REFERENCES

  • Agustí A: Systemic effects of chronic obstructive pulmonary disease: what we know and what we don't know (but should). Proc Am Thorac Soc. 2007;4:522–525.
  • Wright JL, Churg A: Animal models of cigarette smoke-induced chronic obstructive pulmonary disease. Expert Rev Respir Med. 2010;4:723–734.
  • Stolk J, Rudolphus A, Davies P, Osinga D, Dijkman JH, Agarwal L, Keenan KP, Fletcher D, Kramps JA: Induction of emphysema and bronchial mucus cell hyperplasia by intratracheal instillation of lipopolysaccharide in the hamster. J Pathol. 1992;167:349–356.
  • Lucey EC, Goldstein RH, Stone PJ, Snider GL: Remodeling of alveolar walls after elastase treatment of hamsters: results of elastin and collagen mRNA in situ hybridization. Am J Respir Crit Care Med. 1998;158:555–564.
  • Boyd RL, Fisher MJ, Jaeger MJ: Non-invasive lung function tests in rats with progressive papain-induced emphysema. Respir Physiol. 1980;40:181–190.
  • Taraseviciene-Stewart L, Scerbavicius R, Choe KH, Moore M, Sullivan A, Nicolls MR, Fontenot AP, Tuder RM, Voelkel NF: An animal model of autoimmune emphysema. Am J Respir Crit Care Med. 2005;171:734–742.
  • Taraseviciene-Stewart L, Kraskauskas D, Lee JH, Hanaoka M, Burns N, Parr J, Kraskauskiene V, Voelkel NF: Cigarette smoke extract (CSE)-induced emphysema in mice [abstract]. Am J Respir Crit Care Med. 2007;175:A529.
  • Chen Y, Hanaoka M, Chen P, Droma Y, Voelkel NF, Kubo K: Protective effect of beraprost sodium, a stable prostacyclin analog, in the development of cigarette smoke extract-induced emphysema. Am J Physiol Lung Cell Mol Physiol. 2009;296:648–656.
  • Rees AH, Schnieden H: Effects of nicotine, nornicotine and allylnornicotine on the diuretic response to water in rats. Br J Pharmacol Chemother. 1962;18:299–301.
  • Huang JH, Huang XH, Chen ZY, Zheng QS, Sun RY: Dose conversion among different animals and healthy volunteers in pharmacological study. Chinese J Clin Pharmacol Ther. 2004;9:12–14.
  • Chang FH, Hu TM: The influence of tar of cigarettes and three kinds of Chinese herbs and green tea to the activity of ANDM and GST of lives of mice. Prog Vet Med. 2006;2:21–23.
  • Massaro D, Massaro GD: Apoetm1Unc mice have impaired alveologenesis, low lung function, and rapid loss of lung function. Am J Physiol Lung Cell Mol Physiol. 2008;294: 991–997.
  • Lavoie JP, Phan ST, Blais D: Effects of a combination of detomidine and butorphanol on respiratory function in horses with or without chronic obstructive pulmonary disease. Am J Vet Res. 1996;57:705–709.
  • Lapointe JM, Lavoie JP, Vrins AA: Effects of triamcinolone acetonide on pulmonary function and bronchoalveolar lavage cytologic features in horses with chronic obstructive pulmonary disease. Am J Vet Res. 1993;54:1310–1316.
  • Halbower AC, Mason RJ, Abman SH, Tuder RM: Agarose infiltration improves morphology of cryostat sections of lung. Lab Invest. 1994;71:149–153.
  • Choe KH, Taraseviciene-Stewart L, Scerbavicius R, Gera L, Tuder RM, Voelkel NF: Methylprednisolone causes matrix metalloproteinase-dependent emphysema in adult rats. Am J Respir Crit Care Med. 2003;167:1516–1521.
  • Saetta M, Shiner RJ, Angus GE, Kim WD, Wang NS, King M, Ghezzo H, Cosio MG: Destructive index: a measurement of lung parenchymal destruction in smokers. Am Rev Respir Dis. 1985;131:764–769.
  • de Visser YP, Walther FJ, Laghmani el H, Boersma H, van der Laarse A, Wagenaar GT: Sildenafil attenuates pulmonary inflammation and fibrin deposition, mortality and right ventricular hypertrophy in neonatal hyperoxic lung injury. Respir Res. 2009;10:30.
  • Aughsteen AA, Khair AM, Suleiman AA: Quantitative morphometric study of the skeletal muscles of normal and streptozotocin-diabetic rats. JOP. 2006;7:382–389.
  • Abercrombie M: Estimation of nuclear population from microtome sections. Anat Rec. 1946;94:239–247.
  • Benzie IF, Strain JJ: The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem. 1996;239:70–76.
  • Yang Q, Underwood MJ, Hsin MK, Liu XC, He GW: Dysfunction of pulmonary vascular endothelium in chronic obstructive pulmonary disease: basic considerations for future drug development. Curr Drug Metab. 2008;9:661–667.
  • Demedts IK, Demoor T, Bracke KR, Joos GF, Brusselle GG: Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir Res. 2006;7:53.
  • Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, Schulte-Hermann R: In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology. 1995;21:1465–1468.
  • Aoshiba K, Yokohori N, Nagai A: Alveolar wall apoptosis causes lung destruction and emphysematous changes. Am J Respir Cell Mol Biol. 2003;28:555–562.
  • Zemans RL, Colgan SP, Downey GP: Transepithelial migration of neutrophils: mechanisms and implications for acute lung injury. Am J Respir Cell Mol Biol. 2009;40:519–535.
  • Chen HW, Lii CK, Ku HJ, Wang TS: Cigarette smoke extract induces expression of cell adhesion molecules in HUVEC via actin filament reorganization. Environ Mol Mutagen. 2009;50:96–104.
  • van Antwerpen L, Theron AJ, Myer MS, Richards GA, Wolmarans L, Booysen U, van der Merwe CA, Sluis-Cremer GK, Anderson R: Cigarette smoke-mediated oxidant stress, phagocytes, vitamin C, vitamin E, and tissue injury. Ann N Y Acad Sci. 1993;686:53–65.
  • Anderson KM, Seed T, Ou D, Harris JE: Free radicals and reactive oxygen species in programmed cell death. Med Hypotheses. 1999;52:451–463.
  • Rahman I: Oxidative stress, chromatin remodeling and gene transcription in inflammation and chronic lung diseases. J Biochem Mol Biol. 2003;36:95–109.
  • Flores SC, McCord JM: Redox regulation by the HIV-1 tat transcription factor. In: Scandalios JG, ed. Oxidative Stress and the Molecular Biology of Antioxidant Defenses. New York: Cold Spring Harbor Laboratory Press; c1997: 117.
  • Pierrou S, Broberg P, O'Donnell RA, Pawłowski K, Virtala R, Lindqvist E, Richter A, Wilson SJ, Angco G, Möller S, Bergstrand H, Koopmann W, Wieslander E, Strömstedt PE, Holgate ST, Davies DE, Lund J, Djukanovic R: Expression of genes involved in oxidative stress responses in airway epithelial cells of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;175:577–586.
  • Ilumets H, Mazur W, Toljamo T, Louhelainen N, Nieminen P, Kobayashi H, Ishikawa N, Kinnula VL: Ageing and smoking contribute to plasma surfactant proteins and protease imbalance with correlations to airway obstruction. BMC Pulm Med. 2011;11:19.
  • Vecchio D, Arezzini B, Pecorelli A, Valacchi G, Martorana PA, Gardi C: Reactivity of mouse alveolar macrophages to cigarette smoke is strain dependent. Am J Physiol Lung Cell Mol Physiol. 2010;298:704–713.
  • Russell RE, Culpitt SV, DeMatos C, Donnelly L, Smith M, Wiggins J, Barnes PJ: Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2002;26:602–609.
  • Belvisi MG, Bottomley KM: The role of matrix metalloproteinases (MMPs) in the pathophysiology of chronic obstructive pulmonary disease (COPD): a therapeutic role for inhibitors of MMPs? Inflamm Res. 2003;52:95–100.
  • Atkinson JJ, Senior RM: Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol. 2003;28:12–24.
  • Cataldo DD, Gueders MM, Rocks N, Sounni NE, Evrard B, Bartsch P, Louis R, Noel A, Foidart JM: Pathogenic role of matrix metalloproteases and their inhibitors in asthma and chronic obstructive pulmonary disease and therapeutic relevance of matrix metalloproteases inhibitors. Cell Mol Biol (Noisy-le-grand). 2003;49:875–884.
  • Yamada S, Zhang XQ, Kadono T, Matsuoka N, Rollins D, Badger T, Rodesch CK, Barry WH: Direct toxic effects of aqueous extract of cigarette smoke on cardiac myocytes at clinically relevant concentrations. Toxicol Appl Pharmacol. 2009;236:71–77.
  • Man WD, Kemp P, Moxham J, Polkey MI: Skeletal muscle dysfunction in COPD: clinical and laboratory observations. Clin Sci (Lond). 2009;117:251–264.
  • Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H: Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med. 2008;177:743–751.
  • Pennisi E: Genomics: sequence tells mouse, human genome secrets. Science. 2002;298:1863–1865.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.